← Open Payments lookup

THEODORE OSUALA: Open Payments

NPI 1356428833 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,246 in 86 payments from 14 companies in 2025. Trend: 2023 $837 · 2024 $1,185 · 2025 $2,246

Food & beverage: $2,222Education: $24
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$605
Neurocrine BioSciences, Inc.5$245
Otsuka America Pharmaceutical, Inc.10$243
ABBVIE INC.10$207
Lundbeck LLC9$205
Vanda Pharmaceuticals Inc.7$185
E.R. Squibb & Sons, L.L.C.11$178
Teva Pharmaceuticals USA, Inc.7$151
Janssen Pharmaceuticals, Inc5$139
Tris Pharma Inc1$21

Products named: CAPLYTA, REXULTI, INGREZZA, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, FANAPT.

Industry payments across MD — which companies pay providers there.